BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20510034)

  • 1. [Pay attention to some issues on the diagnostic classification of myelodysplastic syndromes and myeloproliferative neoplasms.].
    Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2010 Apr; 31(4):217-8. PubMed ID: 20510034
    [No Abstract]   [Full Text] [Related]  

  • 2. The implications of revised WHO classification (2008) of chronic myeloid neoplasms.
    Găman M; Vlădăreanu AM; Radesi S
    Rom J Intern Med; 2011; 49(1):25-30. PubMed ID: 22026249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid madness: assessing diagnostic inconsistency between the new WHO and ICC schemes for myelodysplastic/myeloproliferative neoplasms.
    Benton LG; Kallen ME; Jacobs JL; McCool IE; Ning Y; Duong VH; Koka R; Singh ZN
    J Clin Pathol; 2023 Dec; 77(1):68-72. PubMed ID: 37696594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic, Prognostic, and Predictive Utility of Recurrent Somatic Mutations in Myeloid Neoplasms.
    Patel U; Luthra R; Medeiros LJ; Patel KP
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S62-S74. PubMed ID: 28760304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Challenge of Treating Myelodysplastic Syndromes/Myeloproliferative Neoplasms.
    Ragon BK; Savona MR
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S37-S42. PubMed ID: 28760301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
    Hall J; Foucar K
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myelodysplastic syndromes--from FAB to WHO classification].
    Kotlarek-Haus S; Haus O
    Pol Arch Med Wewn; 2005 Nov; 114(5):1128-37. PubMed ID: 16789514
    [No Abstract]   [Full Text] [Related]  

  • 8. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric diagnosis of myelodysplasia and myeloproliferative disorders.
    Wood BL
    J Biol Regul Homeost Agents; 2004; 18(2):141-5. PubMed ID: 15471218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in myelodysplastic and myeloproliferative types of chronic myelomonocytic leukemia: a retrospective analysis of 83 patients from a single institution.
    Breccia M; Latagliata R; Mengarelli A; Biondo F; Mandelli F; Alimena G
    Haematologica; 2004 Jul; 89(7):866-8. PubMed ID: 15257942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The WHO classification of the myelodysplastic syndromes.
    Bain B
    Exp Oncol; 2004 Sep; 26(3):166-9. PubMed ID: 15494682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Panmyelopathy and myeloproliferative syndrome].
    Jorke D; Bach G
    Z Gesamte Inn Med; 1986 Nov; 41(21):595-8. PubMed ID: 3469815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloproliferative neoplasms (BCR-ABL1 negative) and myelodysplastic/myeloproliferative neoplasms: current diagnostic principles and upcoming updates.
    Geyer JT; Orazi A
    Int J Lab Hematol; 2016 May; 38 Suppl 1():12-9. PubMed ID: 27161873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topics in pediatric leukemia--myelodysplastic and myeloproliferative disorders of childhood.
    Lasky J; Sakamoto KM
    MedGenMed; 2005 Mar; 7(1):21. PubMed ID: 16369326
    [No Abstract]   [Full Text] [Related]  

  • 15. Next-generation sequencing discriminates myelodysplastic/myeloproliferative neoplasms from paraneoplastic leukemoid reaction in cancer patients with hyperleukocytosis.
    Sakr R; Renneville A; Saada V; Cotteret S; Martin JE; Droin N; Selimoglu-Buet D; Besse B; Hollebecque A; Marzac C; Pasquier F; Micol JB; De Botton S; Mir O; Solary E; Willekens C
    Leuk Lymphoma; 2018 Jul; 59(7):1742-1745. PubMed ID: 29115897
    [No Abstract]   [Full Text] [Related]  

  • 16. Myelodysplastic/myeloproliferative disorders.
    Malcovati L; Cazzola M
    Haematologica; 2008 Jan; 93(1):4-6. PubMed ID: 18166777
    [No Abstract]   [Full Text] [Related]  

  • 17. Myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable; rare cause of granulocytic sarcoma: A diagnostic dilemma.
    Mandal PK; Kumar M; Bhattyacharyya M
    Indian J Pathol Microbiol; 2016; 59(1):133-4. PubMed ID: 26960664
    [No Abstract]   [Full Text] [Related]  

  • 18. [Myelodysplastic syndrome classification].
    Ghariani I; Braham N; Hassine M; Kortas M
    Ann Biol Clin (Paris); 2013; 71(2):139-44. PubMed ID: 23587576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelodysplasia-Related Features of Acute Myeloid Leukemia Evolving From Philadelphia-Negative Myeloproliferative Neoplasms.
    Kim JR; Cho YU; Bae MH; Kim B; Jang S; Seo EJ; Chi HS; Park CJ
    Ann Lab Med; 2016 Jul; 36(4):377-9. PubMed ID: 27139614
    [No Abstract]   [Full Text] [Related]  

  • 20. Speaking a common language in MDS/MPNs.
    Steensma DP
    Blood; 2015 Mar; 125(12):1849-51. PubMed ID: 25792730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.